Genetic Diagnostics and the Rise of Student CEOs | Dr. Jonathan Hill

Could future physicians combine a patient’s genome with artificial intelligence to make faster, more precise diagnoses?Dr. Jonathon Hill returns to BioTalk Unzipped to discuss the convergence of genetics, AI, diagnostics, entrepreneurship, higher education, and biotechnology.Jonathon explains an unusual partnership between academia and industry that allows students to build projects with genuine commercial potential, sometimes moving from student researcher to company founder at an exceptionally young age.The conversation then explores how AI could influence genomic medicine and future diagnosis. Jonathon challenges the traditional trial-and-error model of medicine and considers what could become possible as genetic information and computational tools improve.In New News, the group discusses Lumicell’s fluorescence-guided technology for identifying residual breast-cancer tissue during surgery and what improved visualization could mean for patients.Jonathon also offers advice to students interested in genetics and biotechnology, emphasizing laboratory experience, curiosity, and a willingness to take intelligent risks.The episode closes with a candid look at the regulatory hurdles facing biotechnology companies and a broader question confronting higher education: how can universities give students enough real-world value to justify the growing cost of a degree?Chapters01:01 - Balancing life as a professor while running a laboratory 02:00 - The unique partnership between university and industry 03:55 - Why more students are pursuing entrepreneurship after college 06:31 - How AI may affect genetics research, biotechnology, and future diagnosis 12:58 - New News: Lumicell’s breakthrough in residual breast-cancer imaging 16:10 - Dr. Hill’s passions inside and outside his professional life 17:37 - Advice for young scientists and aspiring biotechnology entrepreneurs 21:00 - Bioinnovation, scientific business training, and concerns about the cost of higher education 28:48 - Regulatory hurdles and progress for Wasatch and its DNA researchConnect with Dr. Jonathon HillDr. Jonathon Hill https://www.linkedin.com/in/jonathon-t-hill/Wasatch Labs https://www.wasatchbiolabs.com/Rainforest Trust https://www.rainforesttrust.org/Connect with the hostsDr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/Gregory Austin https://www.linkedin.com/in/gregoryaustin1/New NewsFDA approval of Lumicell’s fluorescent system for highlighting residual breast cancer: https://www.fiercebiotech.com/medtech/fda-delivers-approval-lumicells-fluorescent-system-highlighting-residual-breast-cancerImage creditsGattaca: https://www.justwatch.com/us/movie/gattaca Lumicell: https://www.fiercebiotech.com/medtech/fda-delivers-approval-lumicells-fluorescent-system-highlighting-residual-breast-cancer Laser Focus World: https://www.laserfocusworld.com/bio-life-sciences/article/14294960/fluorescence-imaging-system-may-improve-cancer-care Vimeo: https://vimeo.com/807609920Keywordsgenetics, nanopore sequencing, AI diagnosis, personalized medicine, biotechnology entrepreneurship, precision medicine, fluorescence imaging, breast cancer, genomic medicine#genetics #AI #personalizedmedicine #biotechnology #breastcancer #diagnostics